1.62BMarket Cap-5882P/E (TTM)
19.930High18.920Low993.94KVolume19.920Open19.880Pre Close19.05MTurnover1.17%Turnover RatioLossP/E (Static)84.99MShares25.34052wk High3.29P/B1.61BFloat Cap11.21552wk Low--Dividend TTM84.65MShs Float29.860Historical High--Div YieldTTM5.08%Amplitude3.390Historical Low19.161Avg Price1Lot Size
Syndax Pharmaceuticals Stock Forum
MT Newswires· 1 min ago
Syndax Pharmaceuticals (SNDX) said late Tuesday the US Food and Drug Administration has granted priority review for the company's new drug application for revumenib to treat relapsed or refractory acute leukemia, a type of cancer.
The company said the filing was assigned a prescription drug user fee act target action date of S...
3 MINUTES AGO, 7:00 AM EDT
VIA PR NEWSWIRE
$Syndax Pharmaceuticals(SNDX.US)$ experienced a 7.10% decline in its stock price during the previous trading session, accompanied by high options activity. The company's option volume reached 36.97K with an IV percentile of 100% and implied volatility ...
$Syndax Pharmaceuticals(SNDX.US)$ experienced a 3.30% increase in stock price during the previous trading session, accompanied by high options activity. The company's option volume peaked at 49.82K with an IV percentile of 94% and a current implied vol...
No comment yet